AI in Remote Patient Monitoring Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - Request a Free Sample

AI in Remote Patient Monitoring Market Overview

AI in Remote Patient Monitoring is advancing healthcare delivery through intelligent data analysis, continuous patient tracking, predictive insights, and automated alerts. These capabilities support timely clinical intervention, improve care coordination, and enable more personalized patient management across healthcare settings. The market is expanding as healthcare providers increasingly adopt connected monitoring technologies and artificial intelligence to manage growing patient volumes. Rising demand for home-based care, chronic disease management, and predictive healthcare is supporting adoption. The market is poised to reach USD 22.55 Billion by 2035.

AI in Remote Patient Monitoring Market Growth Analysis and Key Influencers

AI in Remote Patient Monitoring Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

AI in Remote Patient Monitoring Market Growth Drivers

Rising Demand for Continuous Patient Monitoring Supports Market Value

The growing need for continuous patient monitoring and early detection of health deterioration is strengthening demand for AI-enabled remote monitoring solutions. Healthcare providers increasingly require systems that can analyze real-time patient data and alert clinicians to potential complications. For instance, in October 2022, Apollo Hospitals launched Enhanced Connected Care, an AI-enabled rapid-response monitoring system integrating medical devices and wearables. During trials in Hyderabad and Chennai, the system improved nursing-care efficiency and reduced unexpected complications within two months. Such capabilities are expected to support broader adoption and market expansion.

AI in Remote Patient Monitoring Market Restraints

Ethical and Data-Related Risks May Limit Market Expansion

Ethical concerns surrounding artificial intelligence can hinder the adoption of remote monitoring technologies, particularly when systems influence clinical decisions. According to Behdadi et al., 2026, AI-enabled remote patient monitoring for chronic obstructive pulmonary disease may involve data bias, limited intelligibility of outputs, uneven access, and unclear responsibility. The study also notes that chronic obstructive pulmonary disease affects about 10% of people worldwide, highlighting the importance of reliable monitoring. These concerns may increase implementation requirements and slow market adoption.

AI in Remote Patient Monitoring Market Opportunities

Expansion of Digital Health Platforms Creates New Growth Potential

The expansion of integrated digital health platforms is creating new possibilities for remote patient monitoring across clinical trials and routine care. For instance, in November 2023, AstraZeneca launched Evinova as a health-tech business offering digital health solutions and identified digital remote patient monitoring and digital therapeutics as areas for further development. Its platform supports remote monitoring, telehealth, connected devices, and patient data collection. Such scalable digital ecosystems can broaden access to remote monitoring and create additional avenues for market growth.

AI in Remote Patient Monitoring Market Trends

Some of the notable trends in the market are wearable monitoring, connected care, AI analytics, and out-of-hospital monitoring.

Growing Integration of Wearable Technologies Is Likely to Enhance Market Growth

The market is witnessing a shift toward connected, wearable, and out-of-hospital monitoring that enables continuous visibility across the care journey. For instance, in August 2026, Philips announced collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree, and smartQare to expand wearable and out-of-hospital monitoring within its open ecosystem. The integrations support continuous measurements such as ECG, oxygen saturation, respiration, temperature, and blood pressure, strengthening connected care and supporting market growth.

AI in Remote Patient Monitoring Market Share

Devices Segment Is Positioned to Lead Component-Based Market

The market is segmented by component into devices, software, and services. Among these devices are expected to lead, supported by the growing use of wearable and connected technologies for continuous collection of patient vital signs. For instance, in January 2024, Blue Spark Technologies launched VitalTraq, an AI-enabled multi-sensor remote patient monitoring platform combining contactless remote photoplethysmography with wearable temperature monitoring to capture heart rate, heart rate variability, blood pressure, and respiratory rate. Increasing demand for real-time physiological data is expected to strengthen the device segment.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - Request a Free Sample

AI in Remote Patient Monitoring Market Analysis by Region

The regions included in the report are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these regions, North America is expected to lead, supported by the adoption of regulated digital health and remote monitoring technologies and strong collaboration between healthcare and technology organizations. For instance, in February 2025, Huma announced a collaboration with Pfizer to introduce the Huma Cloud Platform for Hemophilia in the United States. The FDA-cleared RPM platform supports health tracking, treatment adherence, and real-time provider monitoring, reinforcing regional demand for advanced remote care.

Leading Players in the AI in Remote Patient Monitoring Market

AI in Remote Patient Monitoring Market Segmentation

Key Questions Answered in the AI in Remote Patient Monitoring Market Report

• What was the AI in remote patient monitoring market value in 2025?
• What is the AI in remote patient monitoring market forecast outlook for 2026-2035?
• What are the major factors aiding the AI in remote patient monitoring market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major AI in remote patient monitoring market trends?
• Which component is expected to dominate the market segment?
• Which indication is projected to lead the market segment?
• Which end user is likely to dominate the market segment?
• Who are the key players involved in the AI in remote patient monitoring market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

• Primary Research: In-depth consultations with healthcare providers, remote patient monitoring professionals, digital health specialists, technology decision-makers, and key opinion leaders to assess adoption patterns, clinical applications, technology requirements, and purchasing considerations across major regions.
• Secondary Research: Analysis of peer-reviewed literature, clinical and epidemiological studies, regulatory information from the US FDA, EMA, CDSCO, and PMDA, company websites and filings, patent databases, funding records, and industry developments related to AI-enabled monitoring, wearable devices, connected care, and remote patient monitoring.
• Validation: Market estimates are triangulated through top-down and bottom-up modeling, supported by historical market values, company-level analysis, segment-level assessment, regional comparisons, and expert feedback to improve consistency and reliability.